Plain-English translation of NCT07789340 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing radiofrequency ablation (RFA), a procedure that uses carefully controlled heat to interrupt pain signals in the knee. The study compares two techniques: one using a single needle and one using two needles. Both approaches treat the same nerves around the knee that carry pain signals from arthritis.
Chronic knee pain from arthritis can be severely disabling and doesn't always respond well to physical therapy, pain medications, or steroid injections. This trial is testing whether this heat-based treatment can provide relief and whether one technique works better than the other.
You likely qualify if…
You likely don't qualify if…
First, you would receive a test injection of numbing medication near the nerves around your knee to confirm that this treatment might help you. If that test is positive, you would be randomly assigned to receive one of the two radiofrequency ablation techniques. The actual procedure involves placing either one or two small needles near the painful nerves and using heat to reduce their ability to send pain signals. You would be awake during the procedure, which uses imaging guidance to ensure accuracy.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Egypt
Sponsor
Tanta University
Enrollment target
~64 participants
Started
August 2026
Primary completion
June 2027
Age range
50 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mohammed S Elsharkawy, MD
Tanta University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.